McAlpine, K. et al. 2025. Adjuvant pembrolizumab following kidney cancer surgery : A novel patient decision aid to facilitate shared decision-making. Canadian Urological Association Journal. 19, 6 (Apr. 2025), 205–7. DOI:https://doi.org/10.5489/cuaj.9073.